menu search

Prime medicine reports third quarter 2023 financial results and provides business updates

— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...

November 3, 2023, 8:01 pm

Acumen pharmaceuticals presents late-breaker phase 1 updates exploring novel target engagement, dosing regimen and safety findings for acu193 in early alzheimer’s disease at the 16th annual clinical t

– Acumen presented data exploring target engagement modeling of ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibody, to...

October 27, 2023, 1:25 pm

Caixabank to look at how telefonica and stc can cooperate

Spain's Caixabank , a major shareholder in Telefonica , will analyse with the telecoms group any potent...

October 27, 2023, 8:39 am

Poolbeg advisory board endorses flu drug approach

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has secured an endorsement from its scientific advisory board (SAB) of the prioritised targets for...

October 26, 2023, 2:38 am

Surfing the waves with gregor horvat – elliott wave analysis

In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...

October 25, 2023, 10:52 am

Angle technolgy could help provide a more targeted approach to head and neck cancer

ANGLE plc, a leading company in liquid biopsy technology, has unveiled promising research findings that could help transform the treatment of head and...

October 25, 2023, 2:53 am

Moderna and caris life sciences partner to develop mrna oncology therapeutics

Moderna Therapeutics Inc (NASDAQ:MRNA) has teamed up with Texas-headquartered private precision medicine and molecular science firm Caris Life Science...

October 24, 2023, 10:21 am

Moody's to use generative ai to assist with credit risk reporting

Moody's Corporation, one of the big three rating agencies alongside S&P and Fitch, will soon start using artificial intelligence-based large-language ...

October 24, 2023, 7:39 am

United therapeutics: both fundamental and technical analyses justify a buy decision

United Therapeutics Corporation is in a long-term uptrend, reaching a new all-time high, indicating strong demand for the stock. The company has a com...

October 22, 2023, 12:25 pm

Calliditas therapeutics to present seven abstracts at the american society of nephrology (asn) kidney week 2023

STOCKHOLM , Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven ab...

October 19, 2023, 3:58 am

Surfing the waves with gregor horvat – elliott wave analysis

In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...

October 18, 2023, 9:37 am

How to analyse stocks in trading

In this article, we'll explore the art of stock trading analysis, revealing how traders can use it to make informed decisions and place effective trad...

October 18, 2023, 8:21 am

Abb ceo: europe weakest region across business

Björn Rosengren, CEO of ABB, discusses third-quarter earnings and analyses demand across China, Europe...

October 18, 2023, 3:57 am

Iphone 15 sales trail predecessor in china

Chinese consumers are reportedly less enthusiastic about the iPhone 15 than the iPhone 14. Separate analyse...

October 16, 2023, 4:07 pm

Sell the s&p 500 and buy the reit sector

REITs may be a better investment than the S&P 500. In this article, I analyse two scenarios - a recessi...

October 16, 2023, 10:50 am

Merck to present latest research from oncology portfolio at esmo 2023

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...

October 16, 2023, 2:00 am

Eur/usd forecast: us dollar rises amid middle east concerns; german production eyed

Shifting EUR/USD dynamics underscore Middle East unrest and pivotal ECB, FOMC analyses. The post EUR/US...

October 9, 2023, 5:30 am

Aud/usd forecast: will the australian dollar continue to decline in 2023?

Explore the most recent predictions for AUD/USD in 2023-2024. Dive into technical and fundamental analyse...

October 6, 2023, 11:55 am

Japanese yen outlook: usd/jpy in calm waters for now but bullish breakout looms

This article focuses on USD/JPY’s near-term outlook, incorporating both fundamental and technical analyse...

October 4, 2023, 7:35 pm

Verona pharma to present additional analyses of positive phase 3 enhance studies in copd at chest 2023

PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine,  an investigational, novel, se...

October 3, 2023, 2:00 am


Search within

Pages Search Results: